Page last updated: 2024-08-21

alpha-aminopyridine and Thoracic Neoplasms

alpha-aminopyridine has been researched along with Thoracic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bista, R; Carcamo, B; Pacheco, J; Reddy, P; Wilson, H1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Thoracic Neoplasms

ArticleYear
Rapid Response to Lorlatinib in a Patient With TFG-ROS1 Fusion Positive Inflammatory Myofibroblastic Tumor of the Chest Wall Metastatic to the Brain and Refractory to First and Second Generation ROS1 Inhibitors.
    Journal of pediatric hematology/oncology, 2021, 07-01, Volume: 43, Issue:5

    Topics: Adolescent; Aminopyridines; Antineoplastic Agents; Brain; Brain Neoplasms; Humans; Lactams; Male; Myofibroblasts; Neoplasms, Muscle Tissue; Oncogene Proteins, Fusion; Protein-Tyrosine Kinases; Proteins; Proto-Oncogene Proteins; Pyrazoles; Thoracic Neoplasms

2021